Correlation Between Catalyst Pharmaceuticals and Vera Bradley

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Vera Bradley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Vera Bradley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Vera Bradley, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Vera Bradley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Vera Bradley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Vera Bradley.

Diversification Opportunities for Catalyst Pharmaceuticals and Vera Bradley

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Catalyst and Vera is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Vera Bradley in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vera Bradley and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Vera Bradley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vera Bradley has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Vera Bradley go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Vera Bradley

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.75 times more return on investment than Vera Bradley. However, Catalyst Pharmaceuticals is 1.34 times less risky than Vera Bradley. It trades about 0.12 of its potential returns per unit of risk. Vera Bradley is currently generating about -0.07 per unit of risk. If you would invest  1,618  in Catalyst Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  589.00  from holding Catalyst Pharmaceuticals or generate 36.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Vera Bradley

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Vera Bradley 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Vera Bradley are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Vera Bradley may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Catalyst Pharmaceuticals and Vera Bradley Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Vera Bradley

The main advantage of trading using opposite Catalyst Pharmaceuticals and Vera Bradley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Vera Bradley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vera Bradley will offset losses from the drop in Vera Bradley's long position.
The idea behind Catalyst Pharmaceuticals and Vera Bradley pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes